Cross Country Healthcare ...

NASDAQ: CCRN · Real-Time Price · USD
13.37
0.36 (2.77%)
At close: Aug 15, 2025, 3:59 PM
13.61
1.80%
After-hours: Aug 15, 2025, 05:46 PM EDT

Cross Country Healthcare Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
274.07M 293.41M 309.94M 315.12M 339.77M 379.17M 414.04M 442.29M 540.7M 622.71M 628.22M 636.1M 753.56M 788.73M 640.68M 374.9M 331.83M 329.24M
Cost of Revenue
218.07M 234.75M 247.95M 250.96M 273.69M 306.52M 328.02M 344.93M 417.56M 483.28M 489.28M 492.55M 583.16M 613.94M 493.53M 291.11M 259.24M 257.78M
Gross Profit
56M 58.66M 57.65M 64.16M 66.09M 72.66M 86.02M 97.36M 123.14M 139.42M 138.94M 143.54M 170.41M 174.79M 147.15M 83.79M 72.59M 71.47M
Operating Income
-5.86M -977K -3.43M 2.85M -13.03M 8.11M 13.42M 20.3M 35.19M 43.8M 51.46M 52.17M 78.84M 90.63M 75.96M 26.45M 15.9M 20.99M
Interest Income
702K 681K 535K 1.11M n/a n/a n/a 5K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-5.73M -899K -3.91M 3.39M -19.56M 3.69M 12.97M 19.5M 30.31M 40.12M 46.35M 48.7M 74.15M 87.12M 73.3M 24.64M 14.91M 20.36M
Net Income
-6.66M -490K -3.75M 2.56M -16.05M 2.69M 9.04M 12.81M 21.34M 29.44M 38.79M 34.79M 52.89M 61.98M 77.57M 23.43M 11.55M 19.45M
Selling & General & Admin
50.05M 52.49M 55.57M 54.3M 79.12M 64.54M 67.57M 69.63M 78.94M 84.26M 84.31M 80.22M 86.01M 76.81M 65.77M 52.85M 50.34M 46.33M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
11.81M 7.15M 9.86M 9.86M 212K n/a 255.98M -134K 338.62M 4.9M n/a 3.21M 1.08M 2.72M 154K 375K 204K 37K
Operating Expenses
61.86M 59.63M 65.42M 64.16M 79.12M 64.54M 323.55M 74.17M 417.56M 89.16M 84.33M 83.43M 89.49M 79.53M 68.49M 55.53M 52.54M 48.58M
Interest Expense
549K 543K 608K 550K 568K 462K 586K 669K 3.15M 3.69M 3.52M 3.5M 3.86M 3.52M 2.82M 2.18M 1.2M 671K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a 11.5M n/a n/a n/a 16.1M n/a n/a n/a 9.5M n/a n/a n/a
Cost & Expenses
279.93M 294.38M 313.37M 312.27M 352.8M 371.06M 323.55M 419.1M 417.56M 572.45M 576.75M 575.98M 672.65M 693.47M 562.02M 346.64M 311.78M 306.36M
Income Tax Expense
930K -409K -161K 834K -3.51M 997K 3.93M 6.69M 8.96M 10.68M 7.56M 13.91M 21.26M 25.14M -4.27M 1.21M 3.36M 912K
Shares Outstanding (Basic)
32.49M 32.28M 32.34M 33.02M 33.96M 34.22M 34.48M 34.95M 35.35M 35.86M 36.45M 37.1M 37.47M 37.03M 36.97M 36.96M 36.63M 36.18M
Shares Outstanding (Diluted)
32.49M 32.28M 32.34M 33.06M 33.96M 34.6M 34.69M 35.15M 35.52M 36.56M 36.93M 37.49M 37.76M 37.97M 37.74M 37.58M 37.2M 37.03M
EPS (Basic)
-0.2 -0.02 -0.12 0.08 -0.47 0.08 0.26 0.37 0.60 0.82 1.06 0.94 1.41 1.67 2.10 0.63 0.32 0.54
EPS (Diluted)
-0.2 -0.02 -0.12 0.08 -0.47 0.08 0.26 0.36 0.60 0.81 1.05 0.93 1.40 1.63 2.07 0.62 0.31 0.53
EBITDA
-1.08M 4.42M 1.03M 8.44M -14.28M 8.79M 18.03M 24.71M 37.89M 48.71M 53.03M 55.42M 81.49M 93.36M 78.84M 29.5M 18.3M 23.28M
EBIT
-5.18M -356K -3.31M 3.94M -18.99M 4.15M 13.55M 20.17M 33.45M 43.81M 49.87M 52.2M 78.01M 90.64M 76.12M 26.82M 16.11M 21.03M
Depreciation & Amortization
4.1M 4.77M 4.34M 4.5M 4.72M 4.64M 4.47M 4.54M 4.71M 5.16M 3.16M 3.65M 3.92M 3.29M 3.28M 3.26M 2.86M 2.88M